Mitochondrial dysfunction is a hallmark of ␤-amyloid (A␤)-induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that A␤-binding alcohol dehydrogenase (ABAD) is a direct molecular link from A␤ to mitochondrial toxicity. A␤ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of A␤-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-A␤ interaction and suppresses A␤-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an A␤-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-A␤ interaction may be a therapeutic target in AD.
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Mitochondrial dysfunction is a hallmark of ␤-amyloid (A␤)-induced neuronal toxicity in Alzheimer's disease (AD)
. Here, we demonstrate that A␤-binding alcohol dehydrogenase (ABAD) is a direct molecular link from A␤ to mitochondrial toxicity. A␤ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of A␤-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-A␤ interaction and suppresses A␤-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an A␤-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-A␤ interaction may be a therapeutic target in AD.
Human ABAD (also known as ERAB and HSD-10) was the only protein identified from four positive clones that bound A␤ in a yeast two-hybrid screen against human brain and HeLa cDNA libraries (1, 2) . Biochemical characterization has established that the interaction between ABAD and A␤ is highly specific and starts to occur at nanomolar concentrations. At micromolar concentrations, A␤, likely in its oligomeric form, inhibits ABAD enzymatic activity (1, 3, 4) . ABAD appears to have an essential physiological role in mitochondria (1, 3) , and mutational inactivation of Drosophila ABAD (scully) resulted in a lethal phenotype (5) . ABAD is up-regulated in affected neurons in AD (1) ( fig. S1 ), and coexpression of ABAD with mutant amyloid precursor protein (mAPP) exacerbates A␤-induced cellular oxidant stress and cell death (1, 3) . Thus, we speculated that the interaction of A␤ with ABAD might induce mitochondrial dysfunction.
However, because it had not been established that intracellular A␤ can access mitochondria, it was essential to determine whether ABAD and A␤ interact in pathophysiologically relevant settings. To address this directly, we detected ABAD-A␤ complex in AD brains by immunoprecipitating cortical protein extracts with anti-A␤ and then by immunoblotting with anti-ABAD immunoglobulin G (IgG) [ Fig. 1A and supporting online material (SOM) text S1]. Age-matched nondemented brain displayed very little ABAD-A␤ complex. Because cellular and mitochondrial integrity may start to deteriorate soon after death, allowing nonphysiological interactions to occur, we isolated mitochondria from the cerebral cortex of 12-month-old mice expressing mAPP (6) , ABAD (7), or both, driven by the platelet-derived growth factor Bchain promoter (SOM text S2 and S3). The purity of mitochondrial preparations was confirmed by the enrichment of cytochrome c oxidase IV (Cox IV), and the relative absence of lysosomal (cathepsin D) and endoplasmic reticulum [protein disulfide isomerase (PDI)] markers (Fig. 1B) . ABAD-A␤ complex was evident in the mitochondria of both transgenic (Tg) mAPP and Tg mAPP/ABAD mice ( fig. S2A ). Similar bands were only present at very low levels in samples from age-and strainmatched non-Tg littermates or when nonimmune IgG replaced specific antibodies.
We used confocal microscopy to confirm mitochondrial colocalization and interaction of ABAD and A␤. In the cerebral cortex of AD patients, images of anti-ABAD (red) and anti-A␤ (green), detecting endogenous ABAD and A␤, extensively colocalize (Fig. 1C) . Similarly, in the cerebral cortex of Tg mAPP/ABAD mice, there is extensive overlap of immunoreactive ABAD and A␤ ( fig. S2B ). Because ABAD is mainly localized to mitochondria, as shown by the overlap of anti-ABAD (green) and anti-voltage-dependent anion channel (VDAC) (red) images (Fig. 1D ), these data demonstrate that A␤ is also present in the mitochondria of AD patients. Immunogold electron microscopy with gold-conjugated antibody systems provided further evidence for the presence of ABAD and A␤ within mitochondria (18-nm gold particles for ABAD and 12-nm gold particles for A␤). The two different sizes of gold particles are concentrated in the mitochondria of brains from a patient with AD ( Fig. 1E) and from Tg mAPP/ABAD mice ( fig. S2C ). Taken together, these microscopic and immunoprecipitation data demonstrate the formation of ABAD-A␤ complex within mitochondria in vivo.
To determine the structural basis of the ABAD-A␤ interaction, we crystallized and determined the structure of human ABAD in the presence of a molar excess of NAD and A␤ at 2.3 Å resolution ( Fig. 2A, table S1 , and SOM text S4). Unexpectedly, NAD is not bound to ABAD in the crystal structure. Under the crystallization condition, A␤ inhibits ABAD activity, but in the absence of A␤, ABAD displays normal activity. This suggests that A␤ prevents NAD binding in the crystal structure, which may be the molecular basis for its inhibition of ABAD activity.
SDS-polyacrylamide gel electrophoresis and N-terminal sequencing of washed and dissolved crystals showed that both ABAD and A␤ are present in the crystals ( fig. S3A ). However, no electron density is observed for A␤, suggesting that A␤ itself and the region of ABAD that binds to A␤ must be disordered in the crystal. To exclude the possibility that A␤ interacts with ABAD nonspecifically, we performed additional experiments, which showed that other amyloid species such as a prion-derived peptide and amylin did not bind to ABAD. In addition, A␤ residues 1 to 42 [A␤(1-42)], A␤(1-40), and A␤ (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) demonstrated dose-dependent binding, whereas A␤(25-35) showed no specific binding (table S2) .
The comparison of the A␤-bound ABAD structure with the rat ABAD structure in complex with NAD (8) and the human ABAD structure in complex with NAD and a small-molecule inhibitor (9) shows that the A␤-bound ABAD displays substantial distortion of the NAD-binding pocket and the catalytic triad (Fig. 2, B and C, and fig. S3B ). The majority of the L D loop, the beginning of the following ␣ D helix, and the latter part of the L F loop of human ABAD are disordered. Although the L E loop is ordered, the conformation of the loop and the beginning of the following ␣ E helix is markedly different from the structure without A␤.
In the absence of substrate, the L F loop is also disordered in the rat ABAD structure in complex with NAD, whereas the L D loop region is well ordered, suggesting that A␤ binding may have influenced the L D loop dynamics and conformation. In addition, within the NAD-dependent short-chain dehydrogenase/reductase (SDR) superfamily, the L D loop of ABAD from different species contains a unique insertion that is absent in all other SDRs ( fig. S3C ). Because ABAD is the only SDR that has been observed to bind A␤, we hypothesize that the L D loop may be a recognition site for A␤.
Inspection of crystal packing showed that the ordered ends of the L D loop point into huge interconnected solvent channels with estimated dimensions of 70 Å (Fig. 2D) . It is estimated that the ordered part of the crystal only occupies about 30% of the total crystal volume. Sufficient space is therefore available for the disordered loops and the bound A␤, which could drift freely in the large solvent channels in the crystal to cause disorder or nonspecifically bind and clog the active-site region to inactivate the enzyme.
To test the idea that the L D loop is important in A␤ interaction, we performed structure-based mutational analyses (Table  1) . Binding studies with A␤ and glutathione S-transferase (GST)-ABAD truncation mutants showed that the N-terminal portion 
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of ABAD (residues 1 to 158) is responsible for A␤ interaction. (S98A), K99A, and Y101A mutations exhibited no specific interaction to A␤ in a surface plasmon resonance experiment, although wild-type ABAD displayed dosedependent interaction with A␤ (Fig. 3A) .
To determine whether the L D loop is sufficient for A␤ interaction, we synthesized a peptide encompassing this region (residues 92 to 120) of human ABAD [termed ABAD decoy peptide (ABAD-DP)] and used surface plasmon resonance to test its ability to inhibit the interaction of intact ABAD with A␤ ( To develop a specific inhibitor of the ABAD-A␤ interaction in cultured neurons, we added the cell-membrane transduction domain of the human immunodeficiency virus-1 (HIV-1) Tat protein (11, 12) to ABAD-DP and ABAD-RP (thereby enabling the peptides to cross cell membranes). We used cytochrome c release from mitochondria as a marker of A␤-induced cellular stress and apoptosis (SOM text S6). Whereas cultured wild-type cortical neurons exposed to A␤(1-42) suffered loss of cytochrome c from the mitochondrial or membrane fraction to the cytosol fraction, preincubation of the cells with ABAD-DP but not with ABAD-RP largely prevented A␤-induced cytochrome c release (Fig. 3C) . Similarly, ABAD-DP protected against A␤-induced mitochondrial cytochrome c release in neurons from Tg ABAD mice, although these neurons displayed enhanced cytochrome c release compared with that of non-Tg mice. Furthermore, pretreatment with ABAD-DP but not with ABAD-RP markedly reduced spontaneous loss of cytochrome c from the mitochondrial/ membrane fraction of cultured neurons derived from Tg mAPP/ABAD mice.
The protective effects of cell-permeable ABAD-DP are consistent with the hypothesis that the ABAD-A␤ interaction causes mitochondrial stress and apoptosis. Because mitochondria are the principal sites of generation of reactive oxygen species (ROS) under physiologic conditions, and A␤ is known to trigger oxidative stress, we tested whether the protection from A␤-induced cytotoxicity by ABAD-DP is accompanied by an attenuated generation of ROS (SOM text S7). Cultured neurons loaded with a probe for ROS, dichlorofluorescin diacetate (DCFDA), demonstrated fluorescence on exposure to A␤, a phenomenon accentuated in neurons from Tg ABAD mice compared with those of nonTg littermates ( fig. S4B ). Pretreatment with ABAD-DP virtually completely suppressed fluorescence in DCFDA-loaded and A␤-exposed neurons from both non-Tg and Tg ABAD animals ( fig. S4B ). In contrast, there was no effect exerted by ABAD-RP. Furthermore, spontaneous generation of ROS by cultured neurons from Tg mAPP/ ABAD mice was suppressed by pretreatment with ABAD-DP but not ABAD-RP (Fig. 3D) . Linkage between A␤-ABADinduced generation of ROS and subsequent DNA fragmentation (Fig. 3E ) and lactate dehydrogenase (LDH) release ( fig. S4D ) was shown in cultured neurons from Tg mAPP/ABAD mice. Similarly, cultured neurons from Tg ABAD mice exposed to A␤ display subsequent DNA fragmentation ( fig. S4C ) and LDH release ( fig. S4D ). In each case, pretreatment with ABAD-DP but not ABAD-RP attenuated cytotoxicity.
If the above results in cell culture could be extrapolated to in vivo settings, then mice overexpressing ABAD in an A␤-rich environment (i.e., Tg mAPP/ABAD mice) might exhibit exaggerated oxidative stress and elevated generation of ROS. Electron paramagnetic spin resonance (EPR) spectroscopy (SOM text S8) was used to measure the level of ROS in intact frozen brain at 77 K (Fig.  4A) . Notably higher amounts of radicals, as shown by the sharp peak at 3410 G, were observed in the Tg mAPP/ABAD mouse brains, in comparison with brains from non- Tg, Tg ABAD, or Tg mAPP mice. It is evident that this species of free radicals, which might be from ascorbyl or the oneelectron reduced ubiquinone radical, is generated as a result of higher levels of oxidative stress in Tg mAPP/ABAD (13), compared with those of the other genotypes.
Excessive generation of ROS could result in neuronal dysfunction or, alternatively, could be buffered by protective antioxidant mechanisms without changes in neuronal function. We used the radial-arm water maze test (SOM text S9) to detect hippocampaldependent learning and memory deficits in Tg mAPP/ABAD mice (14, 15) . Young mice (4.5 to 5 months of age) of non-Tg, Tg mAPP, or Tg ABAD transgenic littermates all showed strong learning and memory capacity. As they sought out the new platform location, they averaged less than one to two errors by trials 4 or 5 (Fig. 4B) . In contrast, Tg mAPP/ABAD mice failed to learn efficiently and still averaged about four errors by trials 4 or 5 (Fig. 4B) , indicative of severe impairment in spatial and temporal memory. Double transgenic expression of ABAD and mAPP did not cause impairment in vision, motor coordination, or motivation. The visible platform test showed that the four genotypes exhibited no difference in their speed of swimming and in their latencies to find the platform (Fig. 4C ).
Our data demonstrate that ABAD and A␤ directly interact in mitochondria in AD, and that this interaction promotes leakage of ROS, mitochondrial dysfunction, and cell death, potentially underlying the mechanism of A␤-induced mitochondrial toxicity (16) (17) (18) (19) (20) (21) (22) (23) . Such events are likely to induce changes in behavior, characterized by exaggerated impairment of hippocampal function in Tg mAPP/ABAD mice. Taken together, these studies establish that A␤ may exert an important pathogenic role in the mitochondrial compartment through an interaction with ABAD and that inhibition of ABAD-A␤ interaction may provide a new treatment strategy against AD. Instrumental conditioning studies how animals and humans choose actions appropriate to the affective structure of an environment. According to recent reinforcement learning models, two distinct components are involved: a "critic," which learns to predict future reward, and an "actor," which maintains information about the rewarding outcomes of actions to enable better ones to be chosen more frequently. We scanned human participants with functional magnetic resonance imaging while they engaged in instrumental conditioning. Our results suggest partly dissociable contributions of the ventral and dorsal striatum, with the former corresponding to the critic and the latter corresponding to the actor.
The ability to orient toward specific goals in the environment and control actions flexibly in pursuit of those goals is a hallmark of adaptive behavior. Instrumental conditioning, the most basic form of such behavior, allows an organism to learn contingencies between its own responses and rewarding or punishing outcomes (1) (2) (3) (4) (5) . Models of reinforcement learning, such as the actor-critic (6) or advantage learning model (7), provide a twoprocess account of instrumental conditioning. One component, the critic, uses a temporal difference prediction error signal to update successive predictions of future reward associated with being at a state of the external and internal environment (determined by the arrangement of stimuli). The other component, the actor, uses a similar signal to modify stimulus-response or stimulus-responsereward associations in the form of a policy, so that actions associated with greater long-term reward are chosen more frequently on subsequent trials (8) (9) (10) (11) . A putative neuronal correlate of these temporal difference prediction error signals is the phasic activity of dopamine neurons (12) (13) (14) , which send prominent projections to the ventral and dorsal striatum. Lesion and human imaging studies suggest that the ventral and dorsal striatum may have distinct functions. The former is implicated in reward and motivation (15) . The latter is implicated in motor and cognitive control (16) (17) (18) (19) , specifically the learning of stimulus-response associations. On the basis of these findings, a putative neural substrate for reinforcement learning has been proposed (20) , according to which dopaminergic projections to ventral striatum might be involved in reward prediction, corresponding primarily to the critic component of instrumental learning, whereas dopaminergic projections to dorsal striatum might be involved in the modulation of stimulus-response or stimulusresponse-reward associations, corresponding to the instrumental actor.
We analyzed functional magnetic resonance imaging (fMRI) data from human participants performing an instrumental conditioning task. We used a reinforcement learning model called advantage learning (21) to calculate a reward prediction error signal and tested for correlations between that signal and evoked neural activity in the striatum. To dissociate stimulus-response learning from value prediction learning itself, we used a yoked Pavlovian conditioning task as a control condition. This task involves the same value predictions (critic), without action selections (actor). If the ventral striatum corresponds to the critic, then this region should show prediction error activity during both the instrumental and Pavlovian conditioning tasks. If the dorsal striatum corresponds to the actor, then we would expect it to manifest stronger prediction error-related activity during instrumental than during Pavlovian conditioning.
The instrumental task was composed of two trial types: reward and neutral. In the reward trials, participants had to choose between one of two stimuli: one associated with a high probability of obtaining a juice reward (on 60% of occasions) and the other with a low probability of obtaining a juice reward (on 30% of occasions). In neutral trials, participants had to choose between two other stimuli associated with either a high (60%) or low (30%) probability of obtaining an affectively neutral solution. The Pavlovian task was identical to the instrumental task (with both reward and neutral trials), except that the computer made the selection and the participant's task was to indicate which stimulus had been chosen by the computer (Fig. 1A) .
Participants rated the fruit juice as significantly more pleasant than the control tasteless solution in both the instrumental and Pavlovian conditioning tasks (P Ͻ 0.001; Fig. 1B ). In the reward trials of the instrumental task, participants chose the high-probability action significantly more frequently than the low-probability action, but they showed no preference for the highprobability action in the neutral trials (Fig.  1C) . There was evidence of "response matching" in the instrumental task (22) in that the ratio of responses made to the high-probability and low-probability stimuli was 1.92 :1 during reward trials, a value very close to the actual 2 :1 ratio of reward probabilities associated with the two stimuli.
To obtain a behavioral measure of learning in the Pavlovian conditioning task, we tested for differences in reaction times between responses in the reward and neutral trials (pooling over responses to high-and low-probability stimuli) between early and late phases of the session. Participants were faster to respond during the reward trials than during the neutral trials by the second block of trials (Fig. 1D) . 
Methods
Text S1: Immunoprecipitation/immunoblotting. Human brain tissues from AD patients and age-matched non-demented controls (N=3 in each case) were homogenized in Tris buffer (10 mM Tris, 0.1 M NaCl, 1 mM EDTA, 100 µg/ml PMSF, 1µg/ml aprotinin), immunoprecipitated with rabbit anti-Ab IgG (3 µl/500 µg protein, generously provided by Dr. Steven Younkin, Mayo Clinic, Jacksonville, FL) at 4°C overnight, and Western blotting was done with mouse anti-ABAD IgG (1:1000). Immunoprecipitation was performed on incubation of crude extracts (500 mg) from cerebral cortex with anti-Ab antibody followed by immunoblotting with anti-ABAD IgG. Peroxidase-conjugated goat anti-mouse IgG (specific for heavy chain, Jackson Lab) was used as a secondary antibody. Electrophoresis was performed with 12% Tris-Glycine SDS-PAGE. Results shown are representative of the 3 patients in each group. The same methodology was employed for immunoprecipitation/immunoblotting studies of mitochondria derived from brains of Tg mAPP/ABAD mice.
Text S2: Transgenic (Tg) mice overexpressing a mutant human form of amyloid precursor protein (mAPP), the latter a minigene encoding hAPP695, 751 and hAPP770 bearing V717/F, K670M, N671L; J-20 line) in the C57BL6 background were provided by Dr. Lennart Mucke (1) . The latter are termed Tg mAPP mice (>N10 in the C57BL/6 strain). Tg ABAD mice (N8 in the C57BL/6 strain), which overexpress ABAD under control of the PDGF B-chain promoter have described previously (2) . Tg mAPP and Tg ABAD animals were crossed to generated Tg mAPP/ABAD, Tg mAPP, Tg ABAD and nontransgenic littermates. Offspring were identified by PCR using primers for specific for each transgene.
Text S3: Isolation of mitochondria. Brain tissue in isolation buffer (20 mM Hepes at pH 7.2 and 1 mM EDTA) was subjected to 10 strokes of a glass teflon potter homogenizer. The homogenate was centrifuged at 1,700 rpm for 6 min at 4°C. The resulting supernatant was then centrifuged at 5000 g for 10 min. The pellet was resuspended in isolation buffer, and layered on a Ficoll gradient generated from 5 ml of 11% Ficoll and 3 ml of 7.5 % Ficoll and centrifuged in an AH-628 rotor at 79,000g for 30 minutes. The pellet was resuspended again in isolation buffer, incubated with fresh digitonin (1.25 mg/100 mg brain tissues) for 15 min on ice, and then centrifuged at 6,500 rpm for 10 min. The resulting new pellet, containing highly purified mitochondria, was washed with 0.2% BSA and resuspended in isolation buffer.
Text S4: Crystallography. Expression and purification of human ABAD was performed as described (2, 3) . For crystallization, ABAD was concentrated to 10 mg/ml in 25 mM MES at pH 6.0, 0.1 M NaCl and 5 mM DTT and mixed with 5 mM NAD and 3-to 4-fold molar excess of Ab (residues 1-40; Biosource, CA). The mixture was crystallized by vapor diffusion at 22°C using a precipitant solution containing 0.1 M MES at pH 6.0, 2.5 M NaCl, 5 mM benzamidine and 5 mM NAD. Diffraction data were collected at the COM-CAT beamline of Advanced Photon Source and processed with the HKL package (4). The structure was determined by molecular replacement calculations in the program Replace (5, 6) using the rat ABAD structure as a search model. Limited six-dimensional search and a high large term cutoff (2.0) were used in the structure determination. Retrospectively, these strategies were crucial in overcoming the hurdle provided by the high symmetry of the space group and the large conformational differences between rat ABAD and human Ab-bound ABAD structures. Refinement was carried out by the simulated annealing protocol in CNS (7) . Model building was performed in program O and ribbon diagrams were plotted in program SETOR (8, 9) . The final atomic model contains residues 6-94, 114-207 and 229-253.
Text S5: Studies with ABAD-derived peptides. ABAD decoy peptide (ABAD-DP, residues 92-120, with a sequence of Ala-Gly-Ile-Ala-Val-Ala-Ser-Lys-Thr-Tyr-Asn-LeuLys-Lys-Gly-Gln-Thr-His-Thr-Leu-Glu-Asp-Phe-Gln-Arg-Val-Leu-Asp-Val) and ABAD reverse peptide (ABAD-RP, residues 120-92) were synthesized by Biotechnology Lab at Yale University. For binding studies, ABAD was immobilized on CM5 sensor chip (10) . As indicated, Ab(1-40) or Ab(1-42) alone or with either ABAD-DP or ABAD-RP (range of concentrations) was injected at a flow rate of 30 ml/min for 2 min at 25°C using Biacore X (Pharmacia). The reaction/binding buffer contained 50 mM Hepes at pH 7.4, 0.15 M NaCl, 1 mM EDTA, and 0.005% Tween 20. Data analysis was performed using Biacore X biosensor system (Uppsala, Sweden) and BIA evaluation 3.0 software (Biacore, Sweden). Response data are plotted in Resonance Units versus ABAD peptide concentrations (nM), and were fit to a one-site model for competitive inhibition to obtain the K i .
Text S6: The effect of ABAD-DP on cytochrome c release. Primary cortical neurons (4 day) from mice of each of the genotypes were cultured (11) . The effect of ABAD-DP on cytochrome c release was studied by pre-treating cultures with ABAD-DP (10 µM) or ABAD-RP (10 µM) for 60 minutes, followed by incubation with Ab(1-42; 1 µM) for nonTg and Tg ABAD mice. After 24 hours at 37°C, cytosolic cytochrome c was determined by the following procedure. Briefly, cells plated on 100 mm dishes were washed with cold PBS, scraped using a rubber policeman, and collected by centrifugation at 300 g for 5 min at 4°C. The pellet was resuspended in 400 µl of lysis buffer containing 50 mM Tris at pH 7.4, 1 mM EDTA, 1 mM EGTA, 250 mM sucrose, 2 µg/ml leupeptin, 1 mM PMSF, and 1 µg/ml pepstatin A and disrupted with 10 strokes of a Dounce homogenizer. Cytosol and membrane fractions were separated by centrifugation at 105,000 g for 1 hour at 4°C (11) . The resulting pellets were resuspended in 50 µl of lysis buffer and supernatants were concentrated to 20 µl. The protein content of each fraction was determined by the BioRad DC protein assay (BioRad Laboratories, Hercules, CA).
Samples (40 µg/lane) were subjected to 12% SDS-PAGE, followed by immunoblotting using anti-cytochrome c antibody (1:500) (Phamergen).
Text S7: The effect of ABAD-DP on intracellular generation of ROS. Studies were also performed to determine the effect of ABAD-DP on intracellular generation of ROS by neurons from Tg mice using DCFDA fluorescent probe (12, 13) . Cells plated on 100 mm dishes were washed with Hanks balanced saline solution, incubated with 0.05% trypsin-EDTA containing 1 µM DCFDA for 25 minutes and collected by centrifugation at 300 g for 5 min at room temperature. The pellet was resuspended in 1.5 ml Earle's balanced saline solution and exposed to Ab (1-42, 4 mg/ml) for 5 minutes. Fluorescence was measured with excitation at 490 nm and emission at 530 nm using a FluoroMax-2 spectrofluorometer (Jobin Yvon Inc., Edison, NJ). Other studies investigated the effect of ABAD-DP on Ab-induced and spontaneous DNA fragmentation (Cell Death Detection ELISA PLUS , Roche Diagnostics Co. Indianapolis, IN) and LDH release (sigma).
Text S8: EPR spectra were recorded on frozen brain tissues in liquid nitrogen using a quartz dewar at X-band. Brain tissue was extruded in the form of a cylinder with 5 mm diameter at room temperature and quickly frozen in liquid nitrogen. The measurements were performed on frozen intact tissue. No processing (grinding) was done on the frozen sample to avoid artifacts. The spectrometer was set at a frequency of 9.561GHz, a modulation amplitude of 2.5G and a microwave power of 1mW. Spectral acquisitions were performed for 10 min on each sample.
Text S9: The radial-arm water maze task (P<0.05; N=7-8) was performed as previously described. Investigators were blinded to mouse genotypes (14) . Mice had to find a platform hidden beneath the water surface at the end of one of the six arms. The four groups of animals under study in our behavioral experiments were littermates. This breeding strategy and the C57BL/6 background were employed to enhance the reproducibility and reliability of our results in the radial arm water maze, based on work of other investigators. Time to reach the platform and speed of swimming were recorded and analyzed with a video-tracking system (HVS-2020, HVS Image, UK). Figure S1 . Increased expression of ABAD in AD brains (n=19) as compared with agematched controls (n=15). Brains from age-matched, pathologically confirmed 19 patient with AD (means + age 85.5 + 2.07), and 15 non-demented (ND) patients (means + age 82.07 + 1.465) were harvested according to the rapid autopsy procedure developed at Sun Health Institute (postmortem time 2.7 ± 0.306 and 2.14 ± 0.162 hour, respectively, for AD and ND patients) (15) . Two AD-affected brain regions were analysed, inferior temporal lobe grey matter and hippocampus. Protein extracts were prepared by sonication with 5 volumes of extracting buffer (2% SDS, 1mM EDTA, and protease inhibitors in PBS) and 8 mg of protein from each brain extract were loaded onto reducing NuPAGE 4-12% Bis-Tris gel (Invitrogen, Carlsbad, CA). Immunoblotting was performed with specific antibodies to ABAD (monoclonal antibody to human, generated in our lab,1:10,000) or b-actin (1:10,000, Sigma, St. louis, MO). The immunoreactive bands were detected with Super Signal Pico Chemiluminescent substrate (Pierce Chemicals). Densitometry was performed using the Chemilmager 4000 Imaging system (Alpha Innotech, San Leandro, CA) to determine differences in intensity of the ABAD immunoreactive band, which was normalized according to intensity of the b-actin band. Our results demonstrate a significant increase of ABAD protein in the AD-pathologyaffected regions (approximately 28% increase in inferior temporal lobe grey matter and 40% in hippocampus) from AD patients versus ND controls. These data are consistent with our previous data (16) demonstrating enhanced expression of ABAD in AD brain by immunoblotting with anti-ABAD antibody. In contrast, protein extracts prepared from the cerebellum, a region spared from the AD pathology, showed no significant differences between AD patient and ND controls. Mitchondrial fractions (500 mg) from cerebral cortex of nonTg, Tg mAPP and Tg mAPP/ABAD mice were immunoprecipitated with mouse anti-Ab IgG (6E10; 8 µg/ml), or nonimmune IgG (8 µg/ml) at 4°C overnight followed by Western blotting with mouse anti-ABAD (1:10,000). The middle panel shows total input protein reprobed with antiAb antibody (6E 10). Lower panel shows immunoblotting of b-actin for crude extracts from mouse brains. B, Co-localization of ABAD and Ab in the brain of a Tg mAPP/ABAD mouse using confocal microscopy with antibodies to ABAD (red) and Ab (green) (magnification 300-fold). C, Colocalization of ABAD and Ab in mitochondria of brains from Tg mAPP /ABAD mouse using electron microscopy. Double immunogold staining was performed with rabbit anti-Ab IgG and mouse anti-ABAD IgG followed by goat anti-rabbit IgG conjugated to 12 nm gold particles (for Ab1-42) and goat anti-mouse IgG conjugated to 18 nM gold particles (for ABAD). Arrowheads depict gold particles localizing ABAD antigen. The smaller gold particles represent sites of localization of Ab. 
